Bismuth subnitrate/calcium hydroxide Disease Interactions
There is 1 disease interaction with bismuth subnitrate / calcium hydroxide.
Major
Bismuth (applies to bismuth subnitrate/calcium hydroxide) renal dysfunction
Major Potential Hazard, High plausibility.
Bismuth compounds are primarily eliminated by the kidney. Therapy with bismuth compounds should be administered cautiously in patients with renal impairment, and avoided in patients with creatinine clearance < 25 mL/min.
References
- "Product Information. Stomax (bismuth subgallate)." Hope Pharmaceuticals PROD (2001):
Bismuth subnitrate/calcium hydroxide drug interactions
There are 50 drug interactions with bismuth subnitrate / calcium hydroxide.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.